SEC Form 4 · accession 0000921895-16-005122
Enveric Biosciences, Inc. · ENVB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Venkatraman Balakrishnan
Director
Period of report
Jun 28, 2016
Accepted (ET)
Jul 8, 2016 · 2:13 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000890821
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option (Right to Buy)F1 | $6.51 | Jun 28, 2016 | A | 25,000 | A | — | Jun 28, 2022 | Common Stock | 25,000 | 25,000 | D |
| Restricted Stock UnitF2,F3 | — | Jun 28, 2016 | A | 7,680 | A | — | — | Common Stock | 7,680 | 7,680 | D |
Explanation of responses
- F1The options vest on the first anniversary of the grant date.
- F2Each Restricted Stock Unit represents the right to receive, at settlement, one share of common stock.
- F3The Restricted Stock Units vest on the first anniversary of the grant date.